Impact of arterial hypertension on the eye

Current Hypertension Reports

Volumn 14, Issue 6, 2012, Pages 581-590

  Katsi, Vasiliki ^a   Marketou, Maria ^b   Vlachopoulos, Charalambos ^a   Tousoulis, Dimitris ^a   Souretis, George ^a   Papageorgiou, Nikolaos ^a   Stefanadis, Christodoulos ^a   Vardas, Panos ^b   Kallikazaros, Ioannis ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Cardiovascular risk; Eye disease; Hypertension; Hypertensive choroidopathy; Hypertensive retinopathy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; TRANDOLAPRIL;

ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CENTRAL RETINA VEIN OCCLUSION; CHOROID DISEASE; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; EYE BLOOD FLOW; EYE DISEASE; GLAUCOMA; HUMAN; HYPERTENSION; HYPERTENSION CHOROIDOPATHY; HYPERTENSION RETINOPATHY; HYPERTENSIVE CRISIS; MICROANEURYSM; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; PSEUDOEXFOLIATION; RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; RETINA VEIN OCCLUSION; RETROLENTAL FIBROPLASIA; TRABECULOPLASTY;

EYE DISEASES; HUMANS; HYPERTENSION; HYPERTENSIVE RETINOPATHY; RISK FACTORS;

EID: 84870518604     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-012-0283-6     Document Type: Article

References (87)

1. Liew G, Campbell S, Klein R, et al. Ten-year longitudinal changes in retinal microvascular lesions: the atherosclerosis risk in communities study. Ophthalmology. 2011;118:1612-8. This study shows how retinal vascular changes are related to high blood pressure.
2. Wang JJ, Liew G, Wong TY, et al. Retinal vascular calibre and the risk of coronary heart disease-related death. Heart. 2006;92:1583-7.
3. Ibrahim YW, Bots ML, Mulder PG, et al. Number of perifoveal vessels in aging, hypertension and atherosclerosis: the Rotterdam Study. Invest Ophthalmol Vis Sci. 1998;39:1049-53.
4. Haefliger IO, Meyer P, Flammer J, Luescher TF. The vascular endothelium as a regulator of the ocular circulation: new concept in ophthalmology? Surv Ophthalmol. 1994;39:123-32.
5. Hayreh SS. Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension. Curr Opin Ophthalmol. 1999;10:474-82.
6. Xu A, Grunwald JE, Metelitsina TI, et al. Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. Am J Ophthalmol. 2010;150:40-7. This study showed that high BP compromises choroidal circulatory flow.
7. Wang S, Xu L, Jonas JB, et al. Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: The Beijing Eye Study. Ophthalmology. 2009;116:2373-80. This study showed that high blood pressure is associated with retinal microvascular abnormalities.
8. Stanton AV, Wasan B, Cerutti A, et al. Vascular network changes in the retina with age and hypertension. J Hypertens. 1995;13:1724-8.
9. Kutschbach P, Wolf S, Sieveking M, et al. Retinal capillary density in patients with arterial hypertension: 2-year follow-up. Graefes Arch Clin Exp Ophthalmol. 1998;236:410-4.
10. Vaajanen A, Luhtala S, Oksala O, Vapaatalo H. Does the reninangiotensin system also regulate intra-ocular pressure? Ann Med. 2008;40(6):418-27.
11. Wilkinson-Berka JL. Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol. 2006;38:752-65.
12. Wong TY, McIntosh I. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull. 2005;7(73-74):57-70.
13. Klein R, Klein BE, Moss SE, et al. The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study. Trans Am Opthamol Soc. 2006;104:98-107.
14. Klein R, Klein BE, Moss SE, Wang Q. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol. 1994;112:92-8.
15. Klein R, Klein BE, Moss SE. The relation of systemic hypertension to changes in the retinal vasculature. The Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 1997;95:329-50.
16. Sharret AR, Hubbard LD, Cooper LS, et al. Retinal arteriolar diameters and elevated blood pressure. The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1999;150:263-70.
17. Wong TY, Hubbard LD, Klein R, et al. Retinal microvascular abnormalities and blood pressure in older people: the cardiovascular health study. Br J Ophthalmol. 2002;86:1007-13.
18. Wong TY, Klein R, Klein BEK, Meuer SM, Hubbard LD. Retinal vessel diameters and their associations with age and blood pressure. Invest Ophthalmol Vis Sci. 2003;44:4644-50.
19. Wong TY, Klein R, Nieto FJ, et al. Retinal microvascular abnormalities and ten-year cardiovascular mortality. A population-based case-control study. Ophthalmology. 2003;110:933-40.
20. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident clinical strokes. The atherosclerosis risk in the communities study. Lancet. 2001;358:1134-40.
21. Wong TY, Rosamond W, Chang PP, et al. Retinopathy and risk of congestive heart failure. JAMA. 2005;293:63-9.
22. Patton N, Aslam T, Macgillivray T, et al. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat. 2005;206:319-48.
23. Delles C, Michelson G, Harazny J, et al. Impaired endothelial function of the retinal vasculature in hypertensive patients. Stroke. 2004;35:1289-93.
24. Klein R, Sharrett AR, Klein BEK, et al. Are retinal arteriolar abnormalities related to atherosclerosis? The atherosclerosis risk in communities study. Arterioscler Thromb Vasc Biol. 2000;20:1644-50.
25. Katsi V, Vlachopoulos C, Souretis G et al. Association between retinal microcirculation and aortic stiffness in hypertensive patients. Int J Cardiol. 2011 (Epub ahead of print).
26. Nguyen TT, Islam FM, Farouque HM, et al. Retinal vascular caliber and brachial flow mediated dilation: the Multi-Ethnic Study of Atherosclerosis. Stroke. 2010;41:1343-8.
27. Cuspidi C, Sala C. Retinal wall-to-lumen ratio: a new marker of endothelial function? J Hypertens. 2011;28:123-9.
28. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1974;268:336-45.
29. Ikram MK, de Jong FJ, Vingerling JR, et al. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam study. Invest Ophthalmol Vis Sci. 2004;45:2129-34.
30. Wong TY, Klein R, Sharrett AR, et al. The prevalence and risk factors of retinal microvascular abnormalities in older people: the Cardiovascular Health Study. Ophthalmology. 2003;110:658-66.
31. Wong TY, McIntosh R. Systemic associations of retinal microvascular signs: a review of recent population-based studies. Ophthal Physiol Opt. 2005;25:195-204.
32. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28(12):1462-536.
33. Ahmed ME, Walker JM, Beevers DG, Beevers M. Lack of difference between malignant and accelerated hypertension. BMJ (Clin Res Ed). 1986;25(6515):235-7.
34. Pontremoli R, Sofia A, Tirotta A, et al. The deletion polymorphism of the angiotensin l-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol. 1996;7:2550-8.
35. Pontremoli R, Sofia A, Ravera M, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC Study. Hypertension. 1997;30:1135-43.
36. Tanabe Y, Kawasaki R, Wang JJ, et al. Retinal arteriolar narrowing predicts 5-year risk of hypertension in Japanese people: the Funagata study. Microcirculation. 2010;17:94-102. This study showed that retinal arteriolar narrowing may precede the presentation of hypertension by years in initially normotensive individuals.
37. Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar diameters and risk of hypertension. Ann Intern Med. 2004;140:248-55.
38. Dahlof B, Stenkula S, Hansson L. Hypertensive retinal vascular changes before and after treatment. Blood Press. 1992;1:35-44.
39. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998 Sep 12;317 (7160):703-13.
40. Bock KD. Regression of retinal vascular changes by antihypertensive therapy. Hypertension. 1984;6(6 pt 2):III1158-62.
41. Chaturvedi N, Sjolie AK, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet. 1998;351(9095):28-31.
42. Ruggenenti P, Iliev I, Filipponi M, et al. Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trial. J Ophthalmol. 2010;2010:106384. Epub 2010 Jun 10.
43. Sjølie AK, Klein R, Porta M, Orchard T, et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet. 2008;372(9647):1385-93.
44. Wolffsohn JS, Hurcomb PG. Hypertension and the eye. Curr Hypertens Rep. 2002;4:471-6.
45. Luft FC, Mervaala E, Muller DN, et al. Hypertension-induced endorgan damage: a new transgenic approach to an old problem. Hypertension. 1999;33:212-8.
46. Xu A, Grunwald JE, Metelitsina TI, et al. Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. Am J Ophthalmol. 2010;150:40-7.
47. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997;15:486-91.
48. Arakawa S, Yasuda M, Nagata M, et al. Nine-year incidence and risk factors for retinal vein occlusion in a general Japanese population: the Hisayama Study. Invest Ophthalmol Vis Sci. 2011;52 (8):5905-9.
49. Sodi A, Giambene B, Marcucci R, et al. Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion. Retina. 2011;31(4):724-9.
50. O'Mahoney, Wang DT, et al. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008;126:692-9.
51. Wong TY, Scott IU. Clinical practice: retinal vein occlusion. N Engl J Med. 2011;364:979. This article associates retinal vein emboli with vascular risk factors. However, it fails to reveal a relation with risk for death from cardiovascular disease.
52. O'Donnell BA, Mitchell P. The clinical features and associations of retinal emboli. Aust N Z J Ophthalmol. 1992;20:11-7.
53. Mohamed Q, McIntosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology. 2007;114:507-19.
54. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-44.
55. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular agerelated macular degeneration. N Engl J Med. 2006;355:1419-31.
56. Klein R, Klein BE, Jensen SC, Moss SE, Meuer SM. Retinal emboli and stroke: the beaver dam eye study. Arch Ophthalmol. 1999;117:1063-8.
57. Mitchell P, Wang JJ, Li W, Leeder SR, Smith W. Prevalence of asymptomatic retinal emboli in an australian urban community. Stroke. 1997;28:63-6.
58. Wong TY, Klein R. Retinal arteriolar emboli: epidemiology and risk of stroke. Curr Opin Ophthalmol. 2002;13:142-6.
59. Wang JJ, Cugati S, Knudtson MD, et al. Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations. Stroke. 2006;37:1833-6.
60. Wong TY, Larsen EK, Klein R, Mitchell P, Couper DJ, Klein BE, et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the atherosclerosis risk in communities & cardiovascular health studies. Ophthalmology. 2005;112:540-7.
61. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1939;197:332-43.
62. Rabb MF, Gagliano DA, Teske MP. Retinal arterial macroaneurysms. Surv Ophthalmol. 1988;33:73-96.
63. Drance SM. Some factors in the production of low tension glaucoma. Br J Ophthalmol. 1972;56:229-42.
64. LeskeMC. Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings. Curr Opin Ophthalmol. 2009;20:73-8.
65. Leske MC, Connell AM, Wu SY, et al. Risk factors for open-angle glaucoma. The Barbados eye study. Arch Ophthalmol. 1995;113 (7):918-24.
66. Mitchell P, Lee AJ, Rochtchina E, et al. Open-angle glaucoma and systemic hypertension: the blue mountains eye study. J Glaucoma. 2004;13(4):319-26.
67. Memarzadeh F, Ying-Lai M, Chung J, et al. Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci. 2010;51(6):2872-7. This study showed that that low diastolic perfusion pressure is associated with a higher prevalence of glaucoma.
68. Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study. Ophthalmology. 2000;107(7):1287-93.
69. Tielsch JM, Katz J, Sommer A, QuigleyHA, Javitt JC.Hypertension, perfusion pressure, and open-angle glaucoma: a population based assessment. Arch Ophthalmol. 1995;113:216-21.
70. Hayreh SS, Zimmerman MB, Podhajski P, Alward WLM. Nocturnal arterial hypotension and its role in optic nerve and ocular ischemic disorders. Am J Ophthalmol. 1994;117:603-24.
71. Graham SL, Drance SM. Nocturnal hypotension: role in glaucoma progression. Surv Opthalmol. 1999;43(Suppl):10-6.
72. Werne A, Harris A, Moore D, BenZion I, Siesky B. The circadian variations in systemic blood pressure, ocular perfusion pressure, and ocular blood flow: risk factors for glaucoma? Surv Ophthalmol. 2008;53:559-67.
73. Grunwald JE, Piltz J, Hariprasad SM. Optic nerve blood flow in glaucoma: effect of systemic hypertension. Am J Ophthalmol. 1999;127:516-22.
74. Friedman DS, Congdon NG, Kempen J, Tielsch JM, O'Colmain B. Vision Problems in the U. S.: prevalence of adult vision impairment and age-related eye disease. Schaumburg: Prevent Blindness America; 2002.
75. Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol. 1986;104(2):216-9.
76. Leeuwen R, Ikram MK, Vingerling JR, et al. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2003;44:3771-7.
77. Butt AL, Lee ET, Klein R, et al. Prevalence and risks factors of age-related macular degeneration in Oklahoma Indians. The Vision Keepers Study. Opthamology. 2011;118(7):1380-5. This study showed that high systolic BP and high pulse pressure are associated with an increased risk of AMD.
78. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol. 1994;112:500-9.
79. Visontai Z, Horvath T, Kollai M, Hollo G. Decreased cardiovagal regulation in exfoliation syndrome. J Glaucoma. 2008;17:133-8.
80. Miyazaki M, Kubota T, Kubo M, et al. The prevalence of pseudoexfoliation syndrome in a Japanese population: the Hisayama Study. J Glaucoma. 2005;14:482-4.
81. Brajkovic J, Kalauz-Surac I, Ergegovic A, et al. Ocular pseudoexfoliation syndrome and internal systemic diseases. Acta Clin Croat. 2007;46 Suppl 1:57-61.
82. Jonas JB, Grundler AE. Prevalence of diabetes mellitus and arterial hypertension in primary and secondary open-angle glaucomas. Graefes Arch Clin Exp Ophthalmol. 1998;236:202-6.
83. Tarkkanen A, Reunanen A, Kivela T. Frequency of systemic vascular diseases in patients with primary open-angle glaucoma and exfoliation glaucoma. Acta Ophthalmol. 2008;86:598-602.
84. McGill JB. Improving microvascular outcomes in patients with diabetes through management of hypertension. Postgrad Med. 2009;121(2):89-101.
85. Zeraatian S, Zakeri H, Boroojeny SB, et al. Effect of oral clonidine on acute intraocular pressure rise after phacoemulsification: a prospective double-blind, randomized, clinical trial. J Ocul Pharmacol Ther. 2011;27(3):293-7.
86. Graw J, Welzl G, Ahmad N, et al. The KORA Eye Study: a population-based study on eye diseases in Southern Germany (KORA F4). Invest Ophthalmol Vis Sci. 2011;52(10):7778-86.
87. Gill DG, de Mendes CB, Cameron JS, Joseph MC, Ogg CS, Chantler C. Analysis of 100 children with severe and persistent hypertension. Arch Dis Child. 1976;51(12):951-6.